Bengaluru, India

Rajesh Onkardas Bora

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 7.4

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2013-2023

Loading Chart...
Loading Chart...
9 patents (USPTO):

Title: Innovations and Contributions of Rajesh Onkardas Bora

Introduction

Rajesh Onkardas Bora is a prominent inventor based in Bengaluru, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating various diseases. With a total of nine patents to his name, Bora's work has the potential to impact healthcare positively.

Latest Patents

Among his latest patents, Bora has developed substituted nitrogen-containing compounds. These compounds are disclosed as having the formula (I) or a salt thereof, where specific variables are defined. They are particularly noted for their use as inhibitors of ROMK and in pharmaceutical compositions aimed at treating cardiovascular diseases. Another notable patent involves benzofuran derivatives for the treatment of hepatitis C. This disclosure includes compounds of formula (I) and outlines their activity against the hepatitis C virus (HCV), indicating their potential utility in treating infected individuals.

Career Highlights

Throughout his career, Rajesh Bora has worked with notable companies in the pharmaceutical industry. He has been associated with Bristol-Myers Squibb Company and ViiV Healthcare UK (No. 5) Limited. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Bora has collaborated with several professionals in his field, including Manoranjan Panda and Kap-Sun Yeung. These collaborations have likely enhanced his research and development efforts, leading to the successful creation of his patented compounds.

Conclusion

Rajesh Onkardas Bora's contributions to pharmaceutical innovations are noteworthy. His patents reflect a commitment to addressing significant health challenges, particularly in cardiovascular diseases and hepatitis C. His work continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…